Recent Finacing
Recent Raise
Crescendo Biologics is a Cambridge-based clinical-stage immuno-oncology company developing Humabody VH domain–based multi‑functional therapeutics via a transgenic mouse VH discovery platform, including bispecific T‑cell engagers like CB307.